KR960037041A - Mixed Whitening Agent Composition - Google Patents

Mixed Whitening Agent Composition Download PDF

Info

Publication number
KR960037041A
KR960037041A KR1019950008122A KR19950008122A KR960037041A KR 960037041 A KR960037041 A KR 960037041A KR 1019950008122 A KR1019950008122 A KR 1019950008122A KR 19950008122 A KR19950008122 A KR 19950008122A KR 960037041 A KR960037041 A KR 960037041A
Authority
KR
South Korea
Prior art keywords
agent composition
mixed
whitening
whitening agent
aloesin
Prior art date
Application number
KR1019950008122A
Other languages
Korean (ko)
Other versions
KR100202058B1 (en
Inventor
이승기
정명희
박영인
박정일
Original Assignee
이연호
주식회사 남양알로에
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이연호, 주식회사 남양알로에 filed Critical 이연호
Priority to KR1019950008122A priority Critical patent/KR100202058B1/en
Publication of KR960037041A publication Critical patent/KR960037041A/en
Application granted granted Critical
Publication of KR100202058B1 publication Critical patent/KR100202058B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 알부틴 및 코지산으로 구성된 그룹중에서 선택된 제1미백성분, 및 제2미백성분인 알로에신의 배합물을 유효성분으로 함유하는 혼합미백제 조성물에 관한 것이다. 본 발명에 따르는 혼합미백제 조성물은 두가지 성분의 배합물이 존재하기 때문에 각각의 미백작용에 대한 보완작용으로 각각의 성분을 단독으로 사용할 경우에 비해 훨씬 더 소량에서도 월등히 우수한 상승적 미백효과를 나타낼 뿐 아니라 알부틴 및 코지산과 같은 미백성분의 사용량을 줄임으로써 그들에 의한 제품의 제조과정 및 보관중의 착색등의 단점을 극복할 수 있다는 잇점을 제공한다.The present invention relates to a mixed whitening agent composition comprising a combination of the first whitening component selected from the group consisting of arbutin and kojic acid, and aloesin, which is a second whitening component, as an active ingredient. The mixed whitening agent composition according to the present invention exhibits a synergistic whitening effect in a much smaller amount as well as in the case of using each component alone as a supplement to each whitening action because of the presence of a combination of two components. Reducing the amount of whitening ingredients such as kojic acid provides the advantage of overcoming the disadvantages of the manufacturing process and coloring of the products by them.

Description

혼합미백제 조성물Mixed Whitening Agent Composition

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

제1도는 실험예 1에서 측정된 것으로 알로에신과 알부틴의 배합농도 변화에 따른 상승적 티로시나제 활성억제 효과를 비교하여 나타낸 그래프이다 [-*-: 제1군1 is a graph measured in Experiment 1 and comparing the effect of synergistic tyrosinase activity inhibition according to the change in the concentration of aloesin and arbutin [-*-: group 1

(알로에신+0.03mM 알부틴), - □-: 제2군(0.03mM 알로에신+알부틴), - ▲-: 제3군 (알로에신), - ○ -: 제4군(알부틴)], 제2도는 실험예 2에서 측정된 것으로 알로에신과 코지산의 배합농도 변화에 따른 상승적 티로시나제 활성억제 효과를 비교하여 나타낸 그래프이다 [- * -: 제1군(알로에신+0.03mM 코지산), - ○ -: 제2군(0.03mM 알로에신+코지산), - ▲-: 제3군(알로에신), - ■-: 제4군(코지산)].(Aloesin + 0.03mM Arbutin),-□-: Group 2 (0.03mM Aloesin + Arbutin),-▲-: Group 3 (Aloesin),-○-: Group 4 (Arbutin)], 2 is a graph comparing the synergistic tyrosinase inhibitory effect according to the change in the concentration of aloesin and kojic acid measured in Experimental Example 2 [-*-: Group 1 (Aloesin + 0.03mM kojic acid),-○ -: Group 2 (0.03mM aloesin + kojisan),-▲-: group 3 (aloesin),-■-: group 4 (mountain koji)].

Claims (8)

유효성분으로서 알부틴 및 코지산으로 구성된 그룹중에서 선택된 제1미백성분, 및 제2미백성분인 알로에신의 배합물을 함유함을 특징으로 하는 혼합미백제 조성물.A mixed whitening agent composition comprising a combination of the first whitening component selected from the group consisting of arbutin and kojic acid as the active ingredient, and aloesin as the second whitening component. 제 1항에 있어서, 유효성분으로서 알부틴과 알로에신의 배합물을 함유함을 특징으로 하는 혼합미백제 조성물.The mixed whitening agent composition according to claim 1, which contains a combination of arbutin and aloesin as an active ingredient. 제 1항에 있어서, 유효성분으로서 코지산과 알로에신의 배합물을 함유함을 특징으로 하는 혼합미백제 조성물.The mixed whitening agent composition according to claim 1, comprising a combination of kojic acid and aloesin as an active ingredient. 제 1항에 있어서, 제1미백성분과 알로에신이 1:0.1∼10의 중량비로 혼합된 배합물을 함유하는 혼합미백제 조성물.The mixed whitening agent composition according to claim 1, wherein the mixed whitening agent composition comprises a blend in which the first whitening component and aloesin are mixed in a weight ratio of 1: 0.1 to 10. 제 4항에 있어서, 제1미백성분과 알로에신이 1:1∼3의 중량비로 혼합된 배합물을 함유하는 혼합미백제 조성물.The mixed whitening agent composition according to claim 4, wherein the mixed whitening agent composition comprises a blend in which the first whitening component and aloesin are mixed in a weight ratio of 1: 1 to 3. 제 1항에 있어서, 연고제, 팅크제, 비누, 클린싱크림, 콜드크림, 화장수, 밀크로션, 영양크림, 에센스, 파운데이션 또는 백분의 형태로 제형화됨을 특징으로 하는 혼합미백제 조성물.The mixed whitening agent composition according to claim 1, which is formulated in the form of an ointment, tincture, soap, cleansing cream, cold cream, lotion, milk lotion, nutrition cream, essence, foundation or powder. 제 6항에 있어서, 제1미백성분과 알로에신의 배합물이 제형의 총중량을 기준으로 하여 0.01 내지 10중량%의 비로 함유되는 혼합미백제 조성물.7. The mixed whitening agent composition according to claim 6, wherein the combination of the first whitening component and aloesin is contained in a ratio of 0.01 to 10% by weight based on the total weight of the formulation. 제 7항에 있어서, 제1미백성분과 알로에신의 배합물이 제형의 총중량을 기준으로 하여 0.1 내지 3중량%의 비로 함유된 혼합미백제 조성물.The mixed whitening agent composition according to claim 7, wherein the combination of the first whitening component and aloesin is contained in a ratio of 0.1 to 3% by weight based on the total weight of the formulation. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950008122A 1995-04-07 1995-04-07 Mixed whitening compositions KR100202058B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950008122A KR100202058B1 (en) 1995-04-07 1995-04-07 Mixed whitening compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950008122A KR100202058B1 (en) 1995-04-07 1995-04-07 Mixed whitening compositions

Publications (2)

Publication Number Publication Date
KR960037041A true KR960037041A (en) 1996-11-19
KR100202058B1 KR100202058B1 (en) 1999-06-15

Family

ID=19411742

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950008122A KR100202058B1 (en) 1995-04-07 1995-04-07 Mixed whitening compositions

Country Status (1)

Country Link
KR (1) KR100202058B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100374965B1 (en) * 1998-01-08 2003-06-11 주식회사 참 존 Method for stabilizing arbutin and maintaining skin-whitening effect using rutin
KR20030067051A (en) * 2002-02-06 2003-08-14 주식회사 코리아나화장품 Cosmetic Compositions Comprising Lactate and Kojic Acid for Skin Whitening
KR100447441B1 (en) * 1997-06-13 2004-11-03 애경산업(주) Skin whitening agent containing bird's nest extract as tyrosinase inhibiting agent as main component and albutin or kojic acid as auxiliary component

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010086190A (en) * 2000-02-11 2001-09-10 이영준 Skin Whitening Composition with Gymnema Extract
KR20020046034A (en) * 2000-12-12 2002-06-20 안경옥 cream method of producing for toilet

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100447441B1 (en) * 1997-06-13 2004-11-03 애경산업(주) Skin whitening agent containing bird's nest extract as tyrosinase inhibiting agent as main component and albutin or kojic acid as auxiliary component
KR100374965B1 (en) * 1998-01-08 2003-06-11 주식회사 참 존 Method for stabilizing arbutin and maintaining skin-whitening effect using rutin
KR20030067051A (en) * 2002-02-06 2003-08-14 주식회사 코리아나화장품 Cosmetic Compositions Comprising Lactate and Kojic Acid for Skin Whitening

Also Published As

Publication number Publication date
KR100202058B1 (en) 1999-06-15

Similar Documents

Publication Publication Date Title
US6110477A (en) Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
EP0988852A2 (en) Cool feeling composition
CA2251414A1 (en) Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
FR2680466A1 (en) PREPARATION FOR WHITENING THE SKIN.
EP2170255B1 (en) Use of lignan compound for anti-wrinkle treatment
CZ196599A3 (en) Cosmetic cleansing and treating preparation containing extracts of plants and algae
KR20110139527A (en) Self-preserving skin care formulation
US7226583B2 (en) Composition containing leukocyte extract for the whitening or lightening of skin
BG103404A (en) Compositions containing antimycotic formulation and phospholipid
KR960037041A (en) Mixed Whitening Agent Composition
GB2455294A (en) Skin or hair wash formulation
KR970064592A (en) A composition for whitening skin containing astragalinus extract and tyrosinase inhibitor
JPH0588204B2 (en)
JPH04193821A (en) Hair nourishing cosmetic
ES8608880A1 (en) Antiseptic product and method for manufacturing this product.
KR970014745A (en) Skin cosmetics
RU2689156C1 (en) Active additive to perfume and cosmetic products
JP2005035929A (en) Antimicrobial agent and antimicrobial product using the same
KR950031032A (en) Cosmetic composition containing ceramic powder
KR101933164B1 (en) Cosmetic composition for whitening comprising furocoumarin compound
KR940001880A (en) Skin Cleanser Composition Containing Bamboo Salt
JP2023169991A (en) Oral composition and skin external preparation
KR950029342A (en) Beauty soap containing herbal medicine and its manufacturing method
KR970064449A (en) A method of using an mugwort extract as a glucosyl transferase inhibiting active substance and a food or drink containing the same
KR950005292A (en) Whitening cosmetic composition containing ginkgo biloba extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130319

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20140318

Year of fee payment: 16

EXPY Expiration of term